Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 3/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.44 |
| ▸ | MEN1 | O00255 | 3/20 | 0.44 |
| ▸ | TTR | P02766 | 1/20 | 0.44 |
| ▸ | PPOX | P50336 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | LIPE | Q05469 | 4/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15844933 | 0.87 | FFAR1 (0.56) | FFAR1LMNAKMT2AMEN1TTR | |
| SCHEMBL2681468 | 0.87 | FFAR1 (0.56) | FFAR1LMNAKMT2AMEN1TTR | |
| SCHEMBL4889531 | 0.87 | FFAR1 (0.56) | FFAR1LMNAKMT2AMEN1TTR | |
| SCHEMBL39100 | 0.87 | FFAR1 (0.56) | FFAR1LMNAKMT2AMEN1TTR | |
| Quizalofop SCHEMBL7582678 | 0.86 | LMNA (0.48) | FFAR1LMNAKMT2AMEN1TTR | |
| Clodinafop SCHEMBL7578270 | 0.86 | FFAR1 (0.44) | FFAR1LMNAKMT2AMEN1TTR | |
| Fluazifop SCHEMBL9160098 | 0.85 | LIPE (0.51) | FFAR1LMNAKMT2AMEN1POLB | |
| Acifluorfen SCHEMBL7586484 | 0.84 | MEN1 (0.68) | FFAR1LMNAKMT2AMEN1TTR | |
| Diclofop-Methyl SCHEMBL7579170 | 0.83 | FFAR1 (0.47) | FFAR1LMNAKMT2AMEN1TTR | |
| SCHEMBL7583029 | 0.82 | FFAR1 (0.47) | FFAR1LMNAKMT2AMEN1TTR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020004457-A1 | Herbicidal composition | SYNGENTA PARTICIPATIONS AG (CH) | 2002-01-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020004457-A1 | Herbicidal composition | PPOX, ALAD, DDT | FFAR1 4198/4885LMNA 3881/4885KMT2A 2099/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.